Alaunos Therapeutics (TCRT) EBT (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly EBT came in at -$1.0 million in Q1 2026, up 5.59% YoY from -$976454.5 in Q1 2025, and down 13.67% on a QoQ basis from -$907000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) EBT (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 18 years of EBT data on file, last reported at -$1.0 million in Q1 2026.
- Quarterly EBT rose 5.59% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73.2 million (down 1658.13% YoY) and the FY2025 annual result came in at -$217.8 million, down 4426.37% from the prior year.
- EBT eased to -$1.0 million in Q1 2026, from -$907000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of -$755000.0 in Q4 2024 to a low of -$70.1 million in Q2 2025.
- A 5-year average of -$9.0 million and a median of -$8.1 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT soared 90.67% — and 2025, when it plunged 5908.06%.
- Tracing TCRT's EBT over 5 years: stood at -$9.4 million in 2022, then rose by 14.12% to -$8.1 million in 2023, then soared by 90.67% to -$755000.0 in 2024, then fell by 20.13% to -$907000.0 in 2025, then retreated by 13.67% to -$1.0 million in 2026.
- The last three EBT figures came in at -$1.0 million (Q1 2026), -$907000.0 (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 81.49 Mn |
| 10 | Alaunos Therapeutics | 4.26 Mn | 4.13 Mn | - | -952,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -907,000.00 |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -70.05 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -755,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -8.09 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -9.08 Mn |
| Mar 31, 2023 | -10.57 Mn |
| Dec 31, 2022 | -9.42 Mn |
| Sep 30, 2022 | -9.06 Mn |
| Jun 30, 2022 | -9.97 Mn |
| Mar 31, 2022 | -9.79 Mn |
| Dec 31, 2021 | -11.81 Mn |
| Sep 30, 2021 | -22.74 Mn |
| Jun 30, 2021 | -23.81 Mn |